Today, in a peer-reviewed paper published in the prestigious scientific journal Nature, DeepMind offered further details of how exactly its A.I. software was able to perform so well. It has also open-sourced the code it used to create AlphaFold 2 for other researchers to use.
But it’s still not clear when researchers and drug companies will have easy access to AlphaFold’s structure predictions.
Comments are closed.